PT - JOURNAL ARTICLE AU - Yongjie Sha AU - Yuan Xiong AU - Yehua Wang AU - Jason Ong AU - Yuxin Ni AU - Ying Lu AU - Mengyuan Cheng AU - Joseph Tucker AU - Weiming Tang TI - Comparing the effectiveness of secondary distribution of HIV self-testing to testing card referral in promoting HIV testing among men who have sex with men in China: A quasi-experimental study AID - 10.1101/2021.05.09.21256226 DP - 2021 Jan 01 TA - medRxiv PG - 2021.05.09.21256226 4099 - http://medrxiv.org/content/early/2021/05/10/2021.05.09.21256226.short 4100 - http://medrxiv.org/content/early/2021/05/10/2021.05.09.21256226.full AB - Background Social network-based HIV self-testing (HIVST) is useful to promote HIV testing. Secondary distribution is one social network-based method whereby individuals (indexes) access multiple HIVST kits and distribute them to their social networks (alters). This quasi-experimental study compared the effectiveness and cost of two social network-based HIV testing strategies (HIVST secondary distribution and HIV testing card referral) in promoting HIV testing among Chinese men who have sex with men (MSM).Methods MSM aged 18 years or older were recruited in Guangzhou, Guangdong Province. From May to September 2019, indexes recruited during that period could distribute HIVST kits to people within their social network. Indexes recruited from October 2019 to January 2020 could refer HIV testing cards to people within their social network for free facility-based tests. Participants could access 1-5 HIVST kits or testing referral cards for distribution. Alters were encouraged to upload a picture of their test results and complete an online survey. Indexes and alters received an incentive to report test results.Results Two hundred thirty-nine potential participants were assessed for eligibility and 208/245 (84.9%) were eligible. Among those who completed baseline assessment, 154/208 (74.0%) completed one month of follow-up. Overall,106 indexes were recruited in the HIVST arm and 102 in the testing card arm. The two arms had similar socio-demographic characteristics. At the one-month follow-up, 92 indexes in the HIVST arm self-reported having distributed self-test kits to 179 unique alters, and 62 in the testing card arm self-reported having distributed testing referral cards to 26 unique alters. Additionally, 69/92 (75%) in the HIVST arm distributed any test to friends or sexual partners compared to 18/62 (29%) in the testing card arm, with a risk difference of 46% (95% CI 31%, 61%). Indexes in the HIVST arm distributed an average of 1.95 (SD=1.90) tests, compared to 0.42 (SD=0.78) in the testing card arm, with a risk difference of 1.53 (95% CI 1.09, 1.96). Subgroup analysis suggested that indexes in the HIVST arm who self-identified as gay (p = 0.007) or were previously tested for HIV (p = 0.02) were more likely to distribute. The HIVST arm had a higher total cost and higher testing coverage compared to the testing card referral arm. The ICER per alter tested was $52.78.Conclusions Secondary distribution of HIVST engaged more MSM to distribute tests to their social network and reached more MSM for test. MSM who self-identify as gay or who have previously tested for HIV were more effective in distributing tests. Future testing approaches should include HIVST kits in voluntary counselling and testing settings and incorporate digital strategies for secondary distribution.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialChiCTR1900025433Funding StatementThis work was supported by the National Key Research and Development Program of China [grant number 2017YFE0103800]; Academy of Medical Sciences and the Newton Fund [grant number NIF\R1\181020]; the National Institutes of Health [grant numbers NIAID 1R01AI114310-01, NIAID K24AI143471, R25 AI140495]; UNC Center for AIDS Research [grant number NIAID 5P30AI050410]; National Science and Technology Major Project of China [grant number 2018ZX10101-001-001-003]; the National Nature Science Foundation of China [grant numbers 81903371, 81772240]; and Zhuhai Medical and Health Science and Technology Plan Project [grant number 20181117A010064].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was given approval by the ethics review committees at the University of North Carolina at Chapel Hill and the Dermatology Hospital of Southern Medical University. Verbal consent was obtained from all participants who came to the sites and agreed to participate. Signed online consent was accessed from all index participants who completed the baseline survey and alters who submitted their testing results.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are avaliable upon sending requirement to the corresponding author of the manuscript.